Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 12 von 13
Influenza and other respiratory viruses, 2024-02, Vol.18 (2), p.e13255-n/a
2024
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network
Ist Teil von
  • Influenza and other respiratory viruses, 2024-02, Vol.18 (2), p.e13255-n/a
Ort / Verlag
England: John Wiley & Sons, Inc
Erscheinungsjahr
2024
Quelle
Wiley-Blackwell subscription journals
Beschreibungen/Notizen
  • We conducted a multicentre hospital‐based test‐negative case–control study to measure vaccine effectiveness (VE) against PCR‐confirmed influenza in adult patients with severe acute respiratory infection (SARI) during the 2022/2023 influenza season in Europe. Among 5547 SARI patients ≥18 years, 2963 (53%) were vaccinated against influenza. Overall VE against influenza A(H1N1)pdm09 was 11% (95% CI: −23–36); 20% (95% CI: −4–39) against A(H3N2) and 56% (95% CI: 22–75) against B. During the 2022/2023 season, while VE against hospitalisation with influenza B was >55%, it was ≤20% for influenza A subtypes. While influenza vaccination should be a priority for future seasons, improved vaccines against influenza are needed.
Sprache
Englisch
Identifikatoren
ISSN: 1750-2640, 1750-2659
eISSN: 1750-2659
DOI: 10.1111/irv.13255
Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10894713

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX